Opponents of patents often decry them as barriers to innovation and distribution of innovation, but that certainly doesn't seem to have been the case with vaccines for Covid-19. What does the fact that there are multiple, patented and competitive vaccines for Covid-19 tell us about the patent system and the validity of such criticisms?
Join the Institute for Policy Innovation for a World IP Day discussion on Patents and the Vaccines, a follow-up to last year's "Patents and the Pandemic" event.
Monday, April 26, 2021
3:00 PM Central
For additional information or questions please contact
Addie Crimmins at addie@ipi.org or 512.787.8102